Section 12.52.460. Prescription drug order information.

	(a)  Before a pharmacist may fill a prescription drug order, the pharmacist shall obtain the following information:  
		(1) name of the patient or, if the prescription drug order is for an animal, species of the animal and name of the owner;  
		(2) address of the patient unless the prescription drug order is for a noncontrolled substance and the address is readily retrievable on another appropriate, uniformly maintained pharmacy record, such as a patient medication record;  
		(3) name and, if the prescription drug order is for a controlled substance, the address and DEA registration number of the prescribing practitioner;  
		(4) name and strength of the drug prescribed;  
		(5) quantity prescribed;  
		(6) directions for use;  
		(7) date of issue;  
		(8) refills authorized, if any;  
		(9) if a written prescription drug order, the prescribing practitioner's signature; and  
		(10) if a facsimile prescription drug order, the prescribing practitioner's signature, or authorized agent's signature.  
	(b)  At the time of dispensing, a pharmacist shall add the following information to the prescription drug order:  
		(1) unique identification number of the prescription drug order;  
		(2) initials or identification code of the dispensing pharmacist;  
		(3) quantity dispensed, if different from the quantity prescribed;  
		(4) date of dispensing, if different from the date of issue;  
		(5) if the drug was prescribed by generic name or if an equivalent drug product other than the one prescribed was dispensed, for the drug product actually dispensed, at least one of the following:  
			(A) the name of the drug product's manufacturer or distributor;  
			(B) the national drug code number;  
			(C) the short name code; or  
			(D) the trade name.  
	(c)  After oral consultation with the prescribing practitioner, a pharmacist may add the following information to schedule II controlled substance prescriptions:  
		(1) date of issue of the prescription;  
		(2) address of the patient;  
		(3) strength of the drug prescribed;  
		(4) drug dosage form;  
		(5) drug quantity prescribed;  
		(6) directions for use;  
		(7) DEA registration number.  
	(d)  After oral consultation with the prescribing practitioner, a pharmacist may modify the types of information described in (c)(2) - (7) of this section. However, any modification to the information concerning drug quantity must be limited to strength of the drug prescribed and may  not result in an increase in the original total dosage prescribed.  
	(e)  A pharmacist may not change the name of non-generic drugs, the name of the patient, or the signature of the practitioner.  

Authorities

08.80.005;08.80.030

Notes

Reference

12 AAC 52.490
12 AAC 52.500
12 AAC 52.580

Authority

AS 08.80.005 AS 08.80.030

History

Eff. 1/16/98, Register 145; am 9/11/2010, Register 195; am 9/17/2011, Register 199; am 11/16/2012, Register 204